Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−703 JPY
−314.97 B JPY
314.56 B JPY
154.89 M
About SUMITOMO PHARMA CO LTD
Sector
CEO
Toru Kimura
Headquarters
Osaka
Website
Founded
1897
ISIN
JP3495000006
FIGI
BBG000BG6610
Sumitomo Pharma Co., Ltd. engages in manufacture, sale, import, and export of pharmaceutical products. It operates through the Pharmaceutical Business and Other Business segments. The Pharmaceutical Business segment manufactures and sells generic and prescription drugs in Japan, North America, China, and other overseas countries. The Other Business segment division includes food ingredients, additives, chemical products, veterinary drugs, and diagnostic reagents. The company was founded on May 14, 1897 and is headquartered in Osaka, Japan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4506 is 627 JPY — it has decreased by −0.33% in the past 24 hours. Watch SUMITOMO PHARMA CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange SUMITOMO PHARMA CO LTD stocks are traded under the ticker 4506.
4506 stock has risen by 3.75% compared to the previous week, the month change is a −1.77% fall, over the last year SUMITOMO PHARMA CO LTD has showed a 30.08% increase.
We've gathered analysts' opinions on SUMITOMO PHARMA CO LTD future price: according to them, 4506 price has a max estimate of 750.00 JPY and a min estimate of 470.00 JPY. Watch 4506 chart and read a more detailed SUMITOMO PHARMA CO LTD stock forecast: see what analysts think of SUMITOMO PHARMA CO LTD and suggest that you do with its stocks.
4506 reached its all-time high on Dec 6, 2018 with the price of 4,135 JPY, and its all-time low was 279 JPY and was reached on May 30, 2024. View more price dynamics on 4506 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4506 stock is 3.73% volatile and has beta coefficient of 0.57. Track SUMITOMO PHARMA CO LTD stock price on the chart and check out the list of the most volatile stocks — is SUMITOMO PHARMA CO LTD there?
Today SUMITOMO PHARMA CO LTD has the market capitalization of 241.95 B, it has increased by 2.00% over the last week.
Yes, you can track SUMITOMO PHARMA CO LTD financials in yearly and quarterly reports right on TradingView.
SUMITOMO PHARMA CO LTD is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
4506 earnings for the last quarter are −121.23 JPY per share, whereas the estimation was 17.94 JPY resulting in a −775.70% surprise. The estimated earnings for the next quarter are 41.36 JPY per share. See more details about SUMITOMO PHARMA CO LTD earnings.
SUMITOMO PHARMA CO LTD revenue for the last quarter amounts to 90.07 B JPY, despite the estimated figure of 87.80 B JPY. In the next quarter, revenue is expected to reach 92.16 B JPY.
4506 net income for the last quarter is −48.17 B JPY, while the quarter before that showed 15.94 B JPY of net income which accounts for −402.23% change. Track more SUMITOMO PHARMA CO LTD financial stats to get the full picture.
As of Nov 25, 2024, the company has 4.98 K employees. See our rating of the largest employees — is SUMITOMO PHARMA CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SUMITOMO PHARMA CO LTD EBITDA is −54.82 B JPY, and current EBITDA margin is 11.54%. See more stats in SUMITOMO PHARMA CO LTD financial statements.
Like other stocks, 4506 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SUMITOMO PHARMA CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SUMITOMO PHARMA CO LTD technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SUMITOMO PHARMA CO LTD stock shows the neutral signal. See more of SUMITOMO PHARMA CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.